 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
John A Capitman, PhD, Schneider Institute for Health Policy, Brandies University, MS 035, 415 South Street, Brandeis University, Waltham, MA 02454, 781 736 3932, capitman@brandeis.edu, Vanessa Calderon-Rosado, PhD, National Center on Women and Aging, Brandeis University, MS 035, Waltham, MA 02454, and Sarita Malik Bhalotra, MD, PhD, Schneider Institute for Health Policy, Heller School, Brandeis University, 415 South Street, MS 035, Waltham, MA 02454.
As part of the CMS Cancer Prevention Project, a systematic review of relevant scientific reports and other literature was conducted. The goal of this review was to identify interventions and models that address individual, practitioner, organizational, environmental, community and other factors that may have an impact on racial and ethnic disparities in cancer prevention and treatment. The review cut across different types of cancer (e.g., breast, cervical, lung, prostate, colorectal, oral, and stomach), cancer care continuum (i.e., primary prevention, screening, diagnosis and treatment), minority populations, and intervention strategies (e.g., diet, smoking cessation, mammography screening). This search built upon prior systematic reviews and evidenced- based summaries, and expanded to searches in defined inventories and databases, such as Medline, Cochrane Effective Practice and Organization of Care and Social Science Abstracts, among others. In addition, personal contacts with experts on specific cancers were used to identify relevant literature. A theory-based framework for analysis of the factors affecting cancer prevention and treatment was developed by the project team. This framework served as the principle for organizing the depth of data identified and as a tool for selecting and prioritizing the interventions and models. Available data on the efficacy of these interventions and models will be discussed based on the evidence found in the literature.
Learning Objectives:
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.